Citations

Clear

949 citation(s) found for "Li, Bryan".

The effect of β 2 adrenergic‐receptor stimulation on lung fluid balance in heart failure
Taylor, Bryan Joseph, Ceridon, Maile L., Snyder, Eric M., Olson, Thomas P. , Johnson, Bruce D.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 26 | Issue: S1 | Pages: No page available

10.1096/fasebj.26.1_supplement.1130.15 Get It

Background Increased pulmonary capillary pressure and a possible desensitization of lung β 2 adrenergic receptors (β 2 AR) involved in fluid removal mechanisms may increase extravascular lung water (E LW ) in stable heart failure (HF) patients. Whether these patients exhibit increased E LW remains controversial. Purpose To determine if HF patients have elevated E LW versus controls (CTL) and if acute β 2 AR agonist inhalation stimulates fluid removal. Methods/Results 14 stable HF patients and 19 healthy age/gender matched CTL were studied. Lung tissue volume (V tis ) (includes tissue, blood and water) and pulmonary capillary blood volume (Vc) were assessed pre and post nebulized albuterol via CT and rebreathe, respectively. E LW was derived as V tis – Vc. Pre albuterol, E LW was greater in HF vs. CTL (861±241 vs. 739±143 ml, P <0.01), with no difference in V tis (938±246 vs. 830±151 ml, P =0.08). Albuterol decreased V tis (–4±2%, P =0.02) but did not change E LW (739±143 vs. 724±132 ml) ( P >0.05) in CTL. In HF, albuterol decreased both V tis (–5±3%) and E LW (– 4±2%) ( P <0.05). There was a negative relationship between baseline values and the pre to post albuterol change for V tis ( r 2 =0.38) and E LW ( r 2 =0.42) ( P <0.01) in HF. Conclusion Lung fluid is elevated in stable HF patients relative to healthy subjects. Stimulation of β 2 ARs appears to enhance fluid removal in HF, especially in patients with elevated lung water at rest.
Lung fluid regulation at high‐altitude
Summerfield, Doug, Issa, Amine, Kasak, Alex, Johnson, Bruce D., Taylor, Bryan J.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 27 | Issue: S1 | Pages: No page available

10.1096/fasebj.27.1_supplement.1207.12 Get It

Background Whether lung fluid accumulates in acclimating individuals at high altitude (HA) remains controversial. Purpose To assess the effect of HA on lung fluid regulation. Methods/Results Systolic pulmonary artery pressure (sPAP) (echo), lung diffusing capacity for CO (DLCO), pulmonary capillary blood volume (Vc), alveolar‐capillary conductance (Dm) (single breath method), ultrasound lung comets (ULCs) and pulmonary function (PFTs) were assessed in 8 healthy adults at sea‐level and after 1 and 9 days at Mt. Everest Base Camp (EBC), Nepal (5150 m). Also, after 5 days at EBC, DLCO and PFTs were assessed in 5 subjects pre‐and post‐acute albuterol administration. EBC was reached after an 8 d hike at progressively increasing altitudes starting at 2800 m. Altitude exposure increased sPAP, had no effect on DLCO, increased Dm and decreased Vc with a subsequent increase in Dm/Vc, and decreased the number of ULCs (Table 1). There was no change in FVC or FEV 1 but an increase in MEF 50 . Albuterol administration increased PEF (11.85±1.52 vs. 12.40±1.45 L/s) and MEF 50 (4.85±0.77 vs. 6.00±1.30 L/s) but had no effect on DLCO, Dm or Dm/Vc. Conclusion These data suggest that lung fluid is decreased in acclimating healthy humans at high altitude. Funding: Mayo Clinic & The North Face.
Exercise pulmonary gas exchange differentiates type and severity of pulmonary hypertension in heart failure
Smetana, Michael Robert, O’Malley, Kathy A., Johnson, Bruce D. , Taylor, Bryan J. , Frantz, Robert P.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 27 | Issue: S1 | Pages: No page available

10.1096/fasebj.27.1_supplement.1182.6 Get It

Background Heart failure (HF) is associated with impaired exercise pulmonary gas exchange (PGX) that is likely related to the development and severity of pulmonary hypertension (PH). Purpose To determine whether PGX measures differentiate HF patients with reactive PH from patients with passive PH or no PH. Methods/Results Pulmonary arterial pressure (P AP ), pulmonary wedge pressure (P WP ), transpulmonary pressure gradient (TPG) and PGX indices [end‐tidal CO 2 (P ET CO 2 ), ventilatory efficiency (V E /VCO 2 ), O 2 pulse, estimated pulmonary arterial capacitance (GX CAP )] were assessed simultaneously at rest and during cycle exercise in 38 HF patients undergoing right heart catheterization. Post hemodynamic evaluation, patients were classified as having no PH ( n = 12), passive PH ( n = 10) or reactive PH ( n = 16). TPG increased during exercise in all groups but was greater at end exercise in the reactive PH vs. the passive PH and no PH patients (21±9 vs. 14±7 vs. 12±7 mmHg). At an equivalent VO 2 , P ET CO 2 , O 2 pulse and GX CAP were higher and V E /VCO 2 ratio lower in the no PH and, to a lesser extent, in the passive PH vs. the reactive PH subjects (Figure 1). Conclusion Noninvasive measures of PGX during exercise appear to differentiate HF patients with reactive PH from patients with passive PH or no PH and may be a useful adjunct to invasive catheterization in assessing PH type and severity. HL71478, AHA12POST12070084, Gilead Science
Cardiovascular Response to an Inhaled β‐Agonist in Patients with Heart failure, Effect of β‐Blockade
Martínez, Marina González, Johnson, Bruce D. , Snyder, Eric M., Baker, Sarah E. , Taylor, Bryan J.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 27 | Issue: S1 | Pages: No page available

10.1096/fasebj.27.1_supplement.1126.5 Get It

Asthma, chronic obstructive pulmonary disease, and other respiratory disorders often occur concurrently with heart failure (HF). HF patients with respiratory disease can improve lung function and, therefore, quality of life with β‐agonists. Beta‐agonist use remains controversial as it has been linked with increased mortality risk; however, recent studies that account for co‐morbidities find no association between β‐agonist use and mortality. Previous studies exploring the cardiovascular effect of β‐agonist use in HF are primarily retrospective and focus on heart rate (HR). We have previously demonstrated altered cardiovascular function in response to albuterol in healthy subjects. In the present study we sought to comprehensively assess the cardiovascular effects of albuterol sulfate using cardiac output (Q), stroke volume (SV), HR, systolic, diastolic, and mean arterial blood pressure (SBP, DBP, MAP, respectively) and systemic vascular resistance (SVR). We hypothesized that cardiovascular parameters would be altered 30‐minutes following albuterol administration, and that HF patients using β‐blockers would have an attenuated response. Twenty‐two healthy and twenty‐two HF subjects were recruited (age=56±13 vs. 62±12yrs; height=175±10 vs. 176±9cm; weight=78±15 vs. 93±20; BMI=26±4 vs. 30±6; and BSA=2.08±0 vs. 1.93±0m 2 , for healthy and HF, respectively, p<0.05 for weight, BMI, and BSA). We found that HR and Q increased in healthy but not HF subjects at 30min following albuterol. Patients who were not on β‐blockers (n=4, 18%) had an increase in SV and a decrease in SVR with albuterol, while there was no change in patients who were on β‐blockers (n=14, 64%). These data suggest that HF patients have an attenuated cardiovascular response to inhaled albuterol, particularly with concurrent β‐blocker usage.
Sudden Death in the Young: Information for the Primary Care Provider
Erickson, Christopher C. , Salerno, Jack C., Berger, Stuart, Campbell, Robert M. , Cannon, Bryan C. , Christiansen, James L., Pflaumer, Andreas , Snyder, Christopher S. , Srinivasan, Chandra , Valdés, Santiago O. , Vetter, Victoria L. , Zimmerman, Frank, Cannon, Bryan, Christiansen, James, Moffatt, Kody A.

Mayo Clinic

Pediatrics | June 21, 2021 | Volume: 148 | Issue: 1 | Pages: No page available

10.1542/peds.2021-052044 | PMID 34155130 Get It

There are multiple conditions that can make children prone to having a sudden cardiac arrest (SCA) or sudden cardiac death (SCD). Efforts have been made by multiple organizations to screen children for cardiac conditions, but the emphasis has been on screening before athletic competition. This article is an update of the previous American Academy of Pediatrics policy statement of 2012 that addresses prevention of SCA and SCD. This update includes a comprehensive review of conditions that should prompt more attention and cardiology evaluation. The role of the primary care provider is of paramount importance in the evaluation of children, particularly as they enter middle school or junior high. There is discussion about whether screening should find any cardiac condition or just those that are associated with SCA and SCD. This update reviews the 4 main screening questions that are recommended, not just for athletes, but for all children. There is also discussion about how to handle post-SCA and SCD situations as well as discussion about genetic testing. It is the goal of this policy statement update to provide the primary care provider more assistance in how to screen for life-threatening conditions, regardless of athletic status.
Analysis of high altitude cognitive task performance on multiple tests
Issa, Amine, Wentz, Robert J., Herman, Nicole , Summerfield, Doug, Kasak, A., Johnson, Bruce D., Taylor, Bryan J. , Kasak, Alexander J

Mayo Clinic

The FASEB Journal | June 16, 2021 | Volume: 27 | Issue: S1 | Pages: No page available

10.1096/fasebj.27.1_supplement.1207.9 Get It

Background It is documented that cognitive performance can diminish with altitude, but the sensitivity of specific tests have not been investigated. Our objective was to assess and compare cognitive performance from several tests and relate this to quality of sleep and acute mountain sickness (AMS). Methods During an Everest expedition, 3 cognitive tests (Stroop, Trail Making, and a proprietary motor accuracy test) were used along with a questionnaire to assess sleep and AMS. Six athlete climbers and 9 core team members were assessed pre and post‐expedition and at several time points during the expedition (up to 17,500 ft). Results To normalize for individual differences, scores were assessed as % change from baseline. There was no difference in the variation between repeated attempts in a single testing session (0.19<p<0.87), demonstrating that each test was reproducible. There was no decrement in test scores with altitude, nor was there an association with reported sleep quality. The Stroop performance was associated with AMS (p<0.05) and trending with headache (p< 0.15). The in‐house motor test trended towards an association with AMS and headache (p<0.15). However, the trail making test was not associated with AMS/headache. Conclusion With appropriate acclimatization, cognitive performance is maintained at altitude but is linked to presence of headache and AMS. Mayo Clinic and TNF.
Changes in Body Composition and Aerobic Capacity after High Altitude Exposure in Elite Climbers
Carlson, Alex R. , Kasak, A., Issa, Amine, Summerfield, Douglas T. , Miller, Andrew D., Fuglestad, Andrew, Johnson, Bruce D., Kasak, Alexander, Taylor, Bryan J. , Fuglestad, Andrew P.

Mayo Clinic

The FASEB Journal | June 16, 2021 | Volume: 27 | Issue: S1 | Pages: No page available

10.1096/fasebj.27.1_supplement.1207.10 Get It

BACKGROUND High altitude (HA) exposure influences appetite, protein synthesis and breakdown, and aerobic capacity. Thus, HA exposure typically causes weight (wt) loss, while the impact on aerobic capacity upon return to sea level is more variable. OBJECTIVE To examine the influence of hypobaric hypoxia on body composition and exercise capacity in elite HA climbers (n=4, 2 female) acclimating at ≥5,150 m over 2 mo. relative to trekkers (n=8, 0 female) acclimating at 5,150 m over 2 wks (Mt. Everest, Nepal). Each elite climber successfully summited Mt. Everest. METHODS Body composition (DEXA, skin folds, wt) and exercise capacity (treadmill) were assessed before and within 2 wks post HA. RESULTS HA exposure increased Hct and Hb, with peak values of 52±5% and 18±2 g/dl, and 50±3% and 17±1 g/dl for the climbers and trekkers, respectively. HA decreased lean and fat tissue in both the climbers (lean −4.4±2.3%, fat −8.2±4.0%) and trekkers (lean −1.8±1.6%, fat −5.8±6.1%) (all P ≤0.06). No change was observed in skin folds for either group. Wt decreased in the climbers (−5±2%, P <0.03) and trekkers (−3±1%, P <0.01). There was no change in VO 2max pre‐to post‐HA in either group (climbers 3.26 ± 0.37 vs. 3.27 ± 0.61 L/min; trekkers 3.60 ± 0.54 vs. 3.66 ± 0.43 L/min). CONCLUSION HA results in both lean and fat tissue loss in well acclimatized climbers and trekkers with little subsequent impact on aerobic capacity. Mayo Clinic & TNF.
Influence of Inhaled Amiloride on Lung Fluid Regulation During Normobaric Hypoxia in Healthy Humans
Wheatley, Courtney M. , Kasak, A., Carlson, Alex R. , Hulsebus, Minelle L., Snyder, Eric M., Johnson, Bruce D., Baker, Sarah E. , Miller, Andrew D, Kasak, Alexander J, Taylor, Bryan J.

Mayo Clinic

The FASEB Journal | June 16, 2021 | Volume: 27 | Issue: S1 | Pages: No page available

10.1096/fasebj.27.1_supplement.715.9 Get It

Background Fluid flux in the lungs is influenced by factors altering accumulation or removal (e.g., stimulation of epithelium sodium channels, ENaC). Purpose To determine if ENaC are necessary in the normal fluid regulation with simulated altitude exposure. Methods/Results On separate occasions, 19 healthy subjects (27 ± 5 y) received either nebulized amiloride (ENaC antagonist) or placebo (nebulized saline) during 17 h normobaric hypoxia (FIO2 = 12.5%) in a randomized, double‐blind fashion. Lung diffusing capacity for carbon monoxide (DLCO), alveolar‐capillary membrane conductance (Dm) and pulmonary capillary blood volume (Vc) were measured via a rebreathe method before and after hypoxic exposure. DLCO was not different at baseline for the amiloride vs. placebo treatments (19 ± 5 vs. 21 ± 8 mL/min/mmHg). Hypoxic exposure increased Vc but did not change Dm in both treatments (Placebo: Vc = 43 ± 22 vs. 59±23 mL p=0.011, Dm = 35 ± 10 vs. 37 ± 12 mL/min/mmHg p=0.312; Amiloride: Vc = 38 ± 17 vs. 57 ± 22 mL p<0.01, Dm = 31 ± 8 vs. 34 ± 10 mL/min/mmHg p= 0.206). Conclusion Normobaric hypoxia did not differentially affect alveolar‐capillary conductance in amiloride and placebo conditions, suggesting that ENaC do not have a role in normal lung fluid regulation during acute hypoxic exposure. HL71478
Shifts in the fecal microbial community composition are associated with dietary fiber solubility
Yang, Fang , White, Bryan A. , Chia, Nicholas , Schook, Lawrence B.

Mayo Clinic

The FASEB Journal | June 16, 2021 | Volume: 27 | Issue: S1 | Pages: No page available

10.1096/fasebj.27.1_supplement.1056.2 Get It

The impact of diet on the microbial composition in the gastrointestinal tract has been well documented. However, quantitation of the role of diet in shaping microbial composition has been difficult due to the presence of factors such as host genetics and environment. We used two genetically identical pigs housed together as a system for isolating diet‐induced changes in the microbiome. We used a withdrawal design across four 14‐d periods with two diets having different solubility of dietary fiber to study the fecal microbial community by 454‐pyrosequencing of the 16S rRNA gene. Shifts in the fecal microbial community composition were assessed with respect to dietary correlations. Similarity analysis revealed that the gut microbiomes from the two different diets clustered separately. Taxa‐based approaches detected significantly different bacteria composition in two different diets. Diversity analysis showed that bacterial diversity was associated with the level of dietary fiber solubility. To conclude, the impact of diet on gut microbiome composition was isolated from host genetics and environment. Diet‐induced changes in gut microbiome composition were observed and found to be reversible within a short time. Our results show that genetically identical pigs can be used as a model system for assessing the influence of diet and other variables on the composition of the gut microbial community. Grant Funding Source : University of Illinois Agricultural Experiment Station, USDA AG 2008–34480‐19328, USDA AG 2008–34480‐19328, USDA/ARS AG 58–5438‐7–317l, USDA/ARS AG 58–5438‐2–307
Gender and epithelial sodium channel genotype influence the lung fluid response to hypoxic exercise (LB791)
Baker, Sarah , Wheatley, Courtney M. , Johnson, Bruce D., Snyder, Eric M., Taylor, Bryan J.

Mayo Clinic

The FASEB Journal | June 16, 2021 | Volume: 28 | Issue: S1 | Pages: No page available

10.1096/fasebj.28.1_supplement.lb791 Get It

Fluid clearance from the alveolar space is critically dependent on epithelial sodium channels (ENaC). A common polymorphism in the gene encoding the ENaC alpha subunit results in an alanine to threonine substitution (A663T), with higher ENaC channel activity. This variant influences ion and fluid regulation in the lung during exercise and in response to albuterol. We investigated the influence of the threonine variant (T663; AT/TT group) on the lung fluid response to exercise in conditions of normobaric hypoxia, which challenges lung fluid balance. Lung fluid balance was assessed using Exhaled Na + (ENa + ) and the diffusing capacity for carbon monoxide and nitric oxide (DLCO and DLNO, respectively) to determine alveolar‐capillary membrane conductance (Dm). 19 healthy subjects were grouped by ENaC genotype (n=8 vs. 11 for AA and AT/TT, %female=50 vs. 62%, age=27±1 vs. 28±2yrs., ht=171±3 vs. 173±2cm, wt=69±6 vs.72±3kg , BMI=23±1 vs.24±1kg/m 2 ) and completed two overnight visits in a hypoxic tent simulating just over 5,400m. The visits were randomized to inhaled placebo or inhaled amiloride (1.5mg in 5ml normal saline, used to inhibit ENaC activity) with ENa + , DLCO, and Dm assessed at baseline, following 12 hours of hypoxic exposure, and following hypoxic exercise at 65% peak power on a cycle ergometer. We found significant effects of the interaction between gender and ENaC genotype on DLCO, Dm, and Dm corrected for pulmonary capillary blood volume (p<0.05). Specifically, females with the more active T663 variant had a greater diffusing capacity and less ENa + under placebo conditions, suggesting a greater removal of Na + and fluid from the airspace. These results suggest that genetic variation of ENaC may influence lung fluid balance during hypoxia and hypoxic exercise. Grant Funding Source : Supported by HL71478, HL108962‐03, and HL007249